AIM2 inflammasome is activated by pharmacological disruption of nuclear envelope integrity

AIM2 inflammasome is activated by pharmacological disruption of nuclear envelope integrity

Inflammasomes are critical sensors that convey cellular stress and pathogen presence to the immune system by activating inflammatory caspases and cytokines such as IL-1β. The nature of endogenous stress signals that activate inflammasomes remains unclear. Here we show that an inhibitor of the HIV as...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Di Micco, A, Frera, G, Lugrin, J, Jamilloux, Y, Hsu, E, Tardivel, A, De Gassart, A, Zaffalon, L, Bujisic, B, Siegert, S, Quadroni, M, Broz, P, Henry, T, Hrycyna, C, Martinon, F
Natura:	Journal article
Lingua:	English
Pubblicazione:	National Academy of Sciences 2016

Documenti analoghi

Taking AIM at Influenza: The Role of the AIM2 Inflammasome
di: Dianne W. Xu, et al.
Pubblicazione: (2024-09-01)

The aspartyl protease DDI2 drives adaptation to proteasome inhibition in multiple myeloma
di: Mélanie Op, et al.
Pubblicazione: (2022-05-01)

The Role of AIM2 Inflammasome in Knee Osteoarthritis
di: Yang J, et al.
Pubblicazione: (2022-11-01)

Roles of AIM2 Gene and AIM2 Inflammasome in the Pathogenesis and Treatment of Psoriasis
di: Jieyi Wang, et al.
Pubblicazione: (2022-09-01)

Inflammasomes in Host Defense and Autoimmunity
di: Petr Broz
Pubblicazione: (2016-12-01)

Activation and Pharmacological Regulation of Inflammasomes
di: Chen Chen, et al.
Pubblicazione: (2022-07-01)

Detection of ASC Oligomerization by Western Blotting
di: Jérôme Lugrin, et al.
Pubblicazione: (2017-05-01)

The protease DDI2 regulates NRF1 activation in response to cadmium toxicity
di: Sérgio T. Ribeiro, et al.
Pubblicazione: (2022-10-01)

The AIM2 inflammasome is activated in astrocytes during the late phase of EAE
di: William E. Barclay, et al.
Pubblicazione: (2022-04-01)

Role of the AIM2 Inflammasome in Cancer: Potential Therapeutic Strategies
di: Chiara Colarusso, et al.
Pubblicazione: (2025-02-01)

Mitochondrial ROS potentiates indirect activation of the AIM2 inflammasome
di: Deborah D Crane, et al.
Pubblicazione: (2014-08-01)

Pharmacological Inhibitors of the NLRP3 Inflammasome
di: Ayesha Zahid, et al.
Pubblicazione: (2019-10-01)

COVID-19: lipid disruption is pushing the envelope
di: Garret A. FitzGerald
Pubblicazione: (2022-07-01)

AIM2-inflammasome role in systemic lupus erythematous and rheumatoid arthritis
di: E. E. Uresti-Rivera, et al.
Pubblicazione: (2022-09-01)

AIM2 Inflammasome's First Decade of Discovery: Focus on Oral Diseases
di: Lufei Wang, et al.
Pubblicazione: (2020-08-01)

ER-trafficking triggers NRF1 ubiquitination to promote its proteolytic activation
di: Claire Chavarria, et al.
Pubblicazione: (2023-10-01)

Molecular Mechanism for p202-Mediated Specific Inhibition of AIM2 Inflammasome Activation
di: Qian Yin, et al.
Pubblicazione: (2013-07-01)

Assembly mechanism of the inflammasome sensor AIM2 revealed by single molecule analysis
di: Meenakshi Sharma, et al.
Pubblicazione: (2023-12-01)

Discovery of an inhibitor of DNA-driven inflammation that preferentially targets the AIM2 inflammasome
di: Jack P. Green, et al.
Pubblicazione: (2023-05-01)

Tyrosine Dephosphorylation of ASC Modulates the Activation of the NLRP3 and AIM2 Inflammasomes
di: Bezaleel Mambwe, et al.
Pubblicazione: (2019-07-01)

AIM2 inflammasome activation benefits the therapeutic effect of BCG in bladder carcinoma
di: Houhong Zhou, et al.
Pubblicazione: (2022-10-01)

The DNA-sensing AIM2 inflammasome controls radiation-induced cell death and tissue injury
di: Hu, Bo, et al.
Pubblicazione: (2018)

Pharmacological intervention of curcumin via the NLRP3 inflammasome in ischemic stroke
di: Xiaoxue Du, et al.
Pubblicazione: (2023-10-01)

Cytoplasmic DNA and AIM2 inflammasome in RA: where they come from and where they go?
di: Conghui Xu, et al.
Pubblicazione: (2024-10-01)

PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation
di: Min Xie, et al.
Pubblicazione: (2016-10-01)

Shikonin Suppresses NLRP3 and AIM2 Inflammasomes by Direct Inhibition of Caspase-1.
di: Jernej Zorman, et al.
Pubblicazione: (2016-01-01)

Perfluoroalkyl substance pollutants activate the innate immune system through the AIM2 inflammasome
di: Li-Qiu Wang, et al.
Pubblicazione: (2021-05-01)

AIM2 Engages Active but Unprocessed Caspase-1 to Induce Noncanonical Activation of the NLRP3 Inflammasome
di: Larissa D. Cunha, et al.
Pubblicazione: (2017-07-01)

Disruption of glycolytic flux is a signal for inflammasome signaling and pyroptotic cell death
di: Laura E Sanman, et al.
Pubblicazione: (2016-03-01)

Dual Engagement of the NLRP3 and AIM2 Inflammasomes by Plasmodium-Derived Hemozoin and DNA during Malaria
di: Parisa Kalantari, et al.
Pubblicazione: (2014-01-01)

The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors
di: Xiaoyan Zhan, et al.
Pubblicazione: (2023-01-01)

Therapeutic Potential of Pharmacological Targeting NLRP3 Inflammasome Complex in Cancer
di: Gulcin Tezcan, et al.
Pubblicazione: (2021-02-01)

The recombinant BCG ΔureC::hly vaccine targets the AIM2 Inflammasome to induce autophagy and inflammation
di: Saiga, H, et al.
Pubblicazione: (2014)

The impact of AIM2 inflammasome-induced pyroptosis on acute gouty arthritis and asymptomatic hyperuricemia patients
di: Jiyan Chu, et al.
Pubblicazione: (2024-07-01)

A novel role of AIM2 inflammasome-mediated pyroptosis in radiofrequency ablation of hepatocellular carcinoma
di: Feifan He, et al.
Pubblicazione: (2024-11-01)

Artemisia Extract Suppresses NLRP3 and AIM2 Inflammasome Activation by Inhibition of ASC Phosphorylation
di: Su-Bin Kwak, et al.
Pubblicazione: (2018-01-01)

TUDCA alleviates atherosclerosis by inhibiting AIM2 inflammasome and enhancing cholesterol efflux capacity in macrophage
di: Xuyang Wang, et al.
Pubblicazione: (2024-06-01)

Correction: Shikonin Suppresses NLRP3 and AIM2 Inflammasomes by Direct Inhibition of Caspase-1.
di: Jernej Zorman, et al.
Pubblicazione: (2016-01-01)

Effects of serum-clot contact time on second-trimester prenatal screening markers and their stability in serum
di: Bujišić Nada
Pubblicazione: (2010-01-01)

Breaking barriers: noncanonical inflammasome executes blood–brain barrier disruption
di: Martin Dichgans, et al.
Pubblicazione: (2024-08-01)